1. Home
  2. AVD vs CING Comparison

AVD vs CING Comparison

Compare AVD & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Vanguard Corporation ($0.10 Par Value)

AVD

American Vanguard Corporation ($0.10 Par Value)

HOLD

Current Price

$2.44

Market Cap

72.4M

Sector

Industrials

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$5.34

Market Cap

64.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVD
CING
Founded
1969
2012
Country
United States
United States
Employees
N/A
14
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.4M
64.5M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
AVD
CING
Price
$2.44
$5.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$12.00
$34.50
AVG Volume (30 Days)
147.1K
168.9K
Earning Date
03-16-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
61.11
N/A
EPS
N/A
N/A
Revenue
$515,114,000.00
N/A
Revenue This Year
$8.82
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.05
$3.16
52 Week High
$5.92
$11.89

Technical Indicators

Market Signals
Indicator
AVD
CING
Relative Strength Index (RSI) 48.88 57.73
Support Level $2.50 $4.80
Resistance Level $2.68 $5.15
Average True Range (ATR) 0.12 0.28
MACD 0.00 0.05
Stochastic Oscillator 59.37 94.15

Price Performance

Historical Comparison
AVD
CING

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. The company is a manufacturer of specialty solutions that develops and markets safe synthetic, biological, and biorational products for agricultural, commercial, and consumer uses. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: